v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net (loss) income $ (121,563) $ 33,412
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation 25,894 21,807
Amortization of intangibles 25,470 14,683
Non-cash stock-based compensation 20,009 12,396
Non-cash operating lease expense 7,375 6,167
Amortization of convertible debt discount 1,989 1,904
Amortization of debt issue costs 136 133
Gain on investment in and loan receivable from non-consolidated affiliate, net 0 (109,260)
Interest receivable on loan receivable from non-consolidated affiliate 0 (391)
Loss on disposal of assets, net 3,066 166
Gain on sale of assets held for sale (2,048) 0
Write-off of COVID-19 PCR testing inventory and equipment 0 6,061
Other adjustments 1,428 1,222
Changes in assets and liabilities, net    
Accounts receivable, net 136 2,475
Inventories (403) 3,196
Prepaid lease asset 0 (4,435)
Prepaid and other assets (3,605) (11,796)
Accounts payable, operating lease liabilities, deferred taxes, accrued and other liabilities (20,192) 15,313
Net cash used in operating activities (62,308) (6,947)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of marketable securities (73,973) (180,961)
Proceeds from sales and maturities of marketable securities 89,812 44,736
Purchases of property and equipment (26,357) (52,155)
Proceeds from assets held for sale 12,098 0
Business acquisitions, net of cash acquired 0 (419,404)
Loan receivable from non-consolidated affiliate 0 (15,000)
Net cash provided by (used in) investing activities 1,580 (622,784)
CASH FLOWS FROM FINANCING ACTIVITIES    
Repayment of equipment financing obligations (706) (2,537)
Issuance of common stock, net 10,733 12,110
Proceeds from issuance of convertible debt, net of issuance costs 0 334,410
Premiums paid for capped call confirmations 0 (29,291)
Proceeds from equity offering, net of issuance costs 0 408,133
Net cash provided by financing activities 10,027 722,825
Net change in cash, cash equivalents and restricted cash (50,701) 93,094
Cash, cash equivalents and restricted cash, beginning of period 316,827 250,632
Cash, cash equivalents and restricted cash, end of period 266,126 343,726
Reconciliation of cash, cash equivalents and restricted cash to the Consolidated Balance Sheets:    
Cash and cash equivalents 266,126 340,565
Restricted cash, non-current 0 3,161
Total cash, cash equivalents and restricted cash 266,126 343,726
Supplemental disclosure of cash flow information:    
Interest paid 2,145 1,792
Income taxes paid, net 155 113
Supplemental disclosure of non-cash investing and financing information:    
Fair value of common stock issued to fund business acquisition 0 29,174
Purchases of property and equipment included in accounts payable $ 1,144 $ 2,184

Source